PI PHARMA
ActiveSummary
PI PHARMA has been active since 2006 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€161,750) and a net result of €174,639. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 8% of 6,033 sector peers (NACE 46, fiscal year 2025). The computed 12-month bankruptcy probability is 1.4% (low).
Group and network
Part of the group
A.forall Group
9 companies
Group, risk and exposure
Connections & network
The board mandates are listed below; here you explore them as a network.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, scroll to zoom.
Board mandates elsewhere
1 board mandateBoard mandates of this companythis company sits on their board1